Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
Recruiting · NCT06136546 · Registry updated 2025-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab | Cognition Disorders, Cognitive Dysfunction, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cognitive disorder, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Recruiting | Phase 2 | 2025-05-07 | NCT06136546 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |